Antibody fragments for controlled delivery of therapeutic agents.
Verhoeyen
M E
ME
Colworth Laboratories, Sharnbrook, U.K.
van der Logt
C P
CP
Beggs
T S
TS
Davis
P J
PJ
D000818:Animals; D000907:Antibodies, Bacterial / Q000627:therapeutic use; D018033:Antibodies, Bispecific / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000235:genetics / Q000627:therapeutic use; D016503:Drug Delivery Systems; D005949:Glucose Oxidase / Q000627:therapeutic use; D006801:Humans; D018796:Immunoconjugates / Q000235:genetics / Q000627:therapeutic use*; D007128:Immunoglobulin Fragments / Q000235:genetics / Q000627:therapeutic use*; D015202:Protein Engineering; D013291:Streptococcus / Q000276:immunology
D000907:Antibodies, Bacterial; D018033:Antibodies, Bispecific; D000911:Antibodies, Monoclonal; D018796:Immunoconjugates; D007128:Immunoglobulin Fragments; D005949:Glucose Oxidase